FDA Inspection 1270980 — Eurofins BioPharma Product Testing Czech Republic S.R.O.
The FDA completed an inspection of Eurofins BioPharma Product Testing Czech Republic S.R.O. on Jul 24, 2024 in Brno-Jih. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jul 24, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Brno-Jih (Czech Republic)
Additional Details
Mutual Recognition Agreement (MRA)